Ionis Pharmaceuticals, Inc. (IONS)
27.31
-1.02
(-3.60%)
USD |
NASDAQ |
Nov 12, 16:00
27.50
+0.19
(+0.70%)
After-Hours: 04:02
Ionis Pharmaceuticals Market Cap : 4.545B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.545B |
| November 11, 2026 | 4.714B |
| November 10, 2026 | 4.691B |
| November 09, 2026 | 5.159B |
| November 06, 2026 | 6.560B |
| November 05, 2026 | 6.457B |
| November 04, 2026 | 6.650B |
| November 03, 2026 | 6.695B |
| November 02, 2026 | 6.831B |
| October 30, 2026 | 7.209B |
| October 29, 2026 | 7.353B |
| October 28, 2026 | 7.437B |
| October 27, 2026 | 7.281B |
| October 26, 2026 | 7.192B |
| October 23, 2026 | 7.111B |
| October 22, 2026 | 7.273B |
| October 21, 2026 | 7.333B |
| October 20, 2026 | 7.520B |
| October 19, 2026 | 7.351B |
| October 16, 2026 | 7.112B |
| October 15, 2026 | 7.308B |
| October 14, 2026 | 7.073B |
| October 13, 2026 | 7.020B |
| October 12, 2026 | 7.233B |
| October 09, 2026 | 7.500B |
| Date | Value |
|---|---|
| October 08, 2026 | 7.172B |
| October 07, 2026 | 7.315B |
| October 06, 2026 | 7.288B |
| October 05, 2026 | 7.205B |
| October 02, 2026 | 7.212B |
| October 01, 2026 | 7.288B |
| September 30, 2026 | 7.396B |
| September 29, 2026 | 7.601B |
| September 28, 2026 | 7.548B |
| September 25, 2026 | 7.371B |
| September 24, 2026 | 7.257B |
| September 23, 2026 | 7.276B |
| September 22, 2026 | 7.578B |
| September 21, 2026 | 7.437B |
| September 18, 2026 | 7.361B |
| September 17, 2026 | 7.744B |
| September 16, 2026 | 7.427B |
| September 15, 2026 | 7.826B |
| September 14, 2026 | 8.520B |
| September 11, 2026 | 8.979B |
| September 10, 2026 | 9.218B |
| September 09, 2026 | 9.279B |
| September 08, 2026 | 9.393B |
| September 04, 2026 | 9.622B |
| September 03, 2026 | 9.628B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| BridgeBio Pharma, Inc. | 15.32B |
| Biogen, Inc. | 37.02B |
| Ultragenyx Pharmaceutical, Inc. | 1.658B |
| Krystal Biotech, Inc. | 9.058B |
Market Cap Related Metrics
| PS Ratio | 4.684 |
| PEG Ratio | -0.0867 |
| Price to Book Value | 11.55 |
| Price | 27.31 |
| Earnings Yield | -12.19% |
| PEGY Ratio | -0.0867 |